Ochsner Health, a leading nonprofit healthcare provider in the Gulf South, has been selected by the Global Parkinson’s Genetics Program (GP2) as one of six new study sites for the Black and African American Connections to Parkinson’s Disease study.
Opinion piece on using opioid crisis as a blueprint for addressing Xylazine and F2 spread
Kedrion Biopharma Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the company's manufacturing facility in Bolognana, Italy, to produce RYPLAZIM®.
Digital Science is pleased to announce its continued support of the APE Award for Innovation in Scholarly Communication, which is currently open for applications.
A low calorie diet and high intensity exercise can reduce nerve damage in prediabetic mice, according to a Michigan Medicine study. Researchers say findings reinforce the potential of lifestyle factors to treat peripheral neuropathy, a prevalent and painful complication of obesity, prediabetes and type 2 diabetes.
Kettlebell training may help reduce inflammation and increase muscle strength as we age, even in people who have not been physically active in the past. The findings from a new study will be presented at the 2024 Integrative Physiology of Exercise conference, Nov. 20–22, in State College, Pennsylvania.
Soaking in a hot tub may be preferable to an icy cold bath after exercise if the goal is to maintain optimum performance, according to a new study. This is especially true for those competing in back-to-back races in a short time span. The research will be presented at the 2024 Integrative Physiology of Exercise conference, Nov. 20–22, in State College, Pennsylvania.
Females may begin to recover twice as fast as males when it comes to muscle injuries, according to a new study in mice. The findings support the idea of forming individualized treatment plans based on a person’s biological sex. The research will be presented at the 2024 Integrative Physiology of Exercise conference, Nov. 20–22, in State College, Pennsylvania.
In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive Planetary Health", scientists from the University of Vienna, in collaboration with the University of Southampton, Aalborg University and Boston University, have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The study, published in Nature Microbiology, provides new insights into the often-overlooked impact of human-targeted drugs on the microbial communities that play a critical role in human health.
Chronic pain patients using spinal cord stimulators experienced pain relief, improvement in disability and sleep, and reduction in opioid use with fast-acting subperception therapy (FAST). The positive findings continued over a 12-month period.
Dozens of physician-scientists will share research insights at ASH 2024, a breast-cancer survivor chronicles her journey, researchers seek answers for gastric cancer disparities, and taking major steps to reduce lung cancer’s lethal burden are in this month tip sheet from Sylvester Comprehensive Cancer Center.
Algorithms that can detect subtle changes in a person’s voice are emerging as a potential new diagnostic tool for Parkinson’s disease, according to researchers from Iraq and Australia.
The University Psychedelic Education Program (U-PEP) is now LIVE. This program, funded through philanthropic support, aims to broaden access to education about the therapeutic potential of psychedelic medicines. U-PEP achieves this by equipping university faculty, particularly in nursing and social work, with the essential knowledge and resources they need to develop and integrate evidence-based, culturally responsive psychedelic content into their curriculum.
The University of Texas MD Anderson Cancer Center today was awarded nearly $8 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of faculty recruitment as well as lung and colorectal cancer screening and early detection programs to address cancer incidence rates across Texas.
Carin & Roger Ehrenberg Continue Foundational Support for the Human Dimension Program at Hackensack Meridian School of Medicine with $3 Million Gift
A novel study published today in ADLM’s journal, Clinical Chemistry, has found that it takes the human body much longer than previously thought to clear xylazine — one of the most popular emerging drugs of abuse in the U.S. This much-needed insight into how the body processes xylazine could improve treatment of overdose patients who’ve taken it.
Recovery from an autoimmune inflammation of the brain may take three years or more, according to a study published in the November 20, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
For people seeing a neurologist, their age, race, ethnicity and neighborhood may play a role in whether they do so in person or virtually, via telemedicine, according to a study published in the November 20, 2024, online issue of Neurology® Clinical Practice , an official journal of the American Academy of Neurology.
In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for semagludtide for weight loss, diabetes management, or prevention of recurrent cardiovascular events.
As a young man in his mid-20s, Jorge Gómez was one of thousands of Cuban citizens who fled Communism and the island country on a raft in 1994. He would spend 11 months living in a tent city at Guantanamo Bay before being granted asylum into the U.S., where he overcame countless obstacles to build a better life as an engineer and father of four boys. Patience, perseverance, and an eternal sense of optimism sustained him throughout his journey, he says. And it served him well in 2021 when, during a routine visit to his primary care physician, a cancerous growth in his esophagus was discovered. Heeding his doctor’s recommendation, he sought the help of Markus Goldschmiedt, M.D., Clinical Associate Professor of Internal Medicine at UT Southwestern Medical Center, who was building a reputation as one of only a handful of specialists in Dallas-Fort Worth who could offer a highly complex procedure known as endoscopic submucosal dissection (ESD).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right